Manufacturer
34 recalls in our database name Macleods Pharma Usa Inc as the manufacturing or recalling firm.
Of the 34 recalls from Macleods Pharma Usa Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (15%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active pharmaceutical ingredient.
Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active ingredient.
Macleods Pharma USA Inc. is recalling Losartan Potassium and Hydrochlorothiazide tablets because an impurity was detected in the active ingredient.
Macleods Pharma USA Inc. is recalling Losartan Potassium tablets because an impurity was detected in the active ingredient.
Macleods Pharma USA is recalling specific bottles of Losartan Potassium and Hydrochlorothiazide tablets because a carcinogen impurity was detected in the active ingredient.
Macleods Pharma USA is recalling Telmisartan and Hydrochlorothiazide tablets because they failed blend uniformity specifications.
Macleods Pharma USA is recalling Telmisartan and Hydrochlorothiazide tablets because they failed content uniformity specifications for blend uniformity.
Macleods Pharma USA is recalling Telmisartan and Hydrochlorothiazide tablets because they failed blend uniformity specifications. The recall covers 140,589 bottles distributed nationwide.
Macleods Pharma USA is recalling Pramipexole Dihydrochloride tablets due to the presence of a foreign Carbimazole 5 mg tablet.